Acne treatment.
Abstract
A new treatment for acne has been developed. The treatment consists of a topical pharmaceutical formulation containing a biocide, one or more fatty acids and an aliphatic alcohol. Pharmaceutical preparations and a method of treatment are described in the present application.

Term
Term ended
Projected expiry passed 2 March 2009, 17.6 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
11 claims: 4 independent, 7 dependent
- 1A bactericidal composition, for use in the external treatment of acne, comprising a biocide effective in killing acne bacteria, a fatty acid and an aliphatic alcohol.
- 6A composition according to any one of the preceeding claims comprising 0.05 to 10%w/w of a biocide selected from the group comprising parachlorometaxylenol, benzoyl peroxide, triclosan, sulphur, salicylic acid or mixtures thereof, 0.5 to 5.0%w/w linoleic and/or linolenic acid, 24.0 to 95.25%w/w quick breaking foaming agent, and 3 to 30%w/w aerosol propellant.
- 9A composition according to any one of the preceeding claims wherein the biocide is present in an amount of about 0.2%w/w.
- 10A composition according to any one of the preceeding claims wherein the linoleic and/or linolenic acid is present in an amount between about 0.8 and 1.25%w/w.
Independent claims4
39 paragraphs in 3 sections, as filed
The present invention resides in a new biocidal composition which is particularly applicable for use in treatment of acne.
BACKGROUND
Acne is caused by bacterial infection.
In the past, treatment of acne has normally comprised the external application of solutions, lotions or creams containing benzoyl peroxide or such phenolics as resorcinol. Although such treatment may be effective in some instances, the high proportion of instances where external treatment has been largely ineffective has led to the development of internal treatments, administration of which is liable to cause serious side-effects and is therefore highly undesirable except in very extreme cases.
Consequently, it has long been recognised that development of new methods of treating acne is highly desirable.
It has been found that one of the main reasons for the ineffectiveness of the known solutions, lotions and creams is that the active constituents do not reach the appropriate dermal site where treatment is required. Solutions tend to evaporate before penetrating the epidermis, and lotions and creams are generally too viscous to allow penetration of the epidermis.
SUMMARY OF THE INVENTION
The present invention ameliorates the disadvantages of the prior art by providing a synergistic composition comprising a biocide effective in killing acne bacteria, a fatty acid and an aliphatic alcohol.
Such compositions are of low viscosity and are therefore capable of rapid penetration of the epidermis. Preferred biocides are chosen from the group consisting of parachlorometaxylenol (PCMX), Benzoyl Peroxide, Triclosan, Sulphur and Salicylic Acid or mixtures thereof. The preferred fatty acids in the composition of the present invention are linoleic and/or linolenic acid although mixtures with other fatty acids of this type are also suitable. Linoleic and/or linolenic acid is preferably present in an amount of 0.5 - 5%w/w, more preferably of 0.82 - 1.25%w/w composition.
To improve the structure of the composition it may be produced in the form of a quick breaking foam, thus reducing the amount of evaporation on application but at the same time allowing rapid penetration of the epidermis. Quick breaking foams minimise early evaporation as they are applied to the skin surface as a thick foam which rapidly disintegrates when spread.
One preferred composition in the form of a quick breaking foam comprises biocide, linoleic and/or linolenic acid, a quick breaking agent and an aerosol propellant. Preferably a corrosion inhibitor is also included if the composition is to be stored in metal containers. However, this is not necessary if the container is of non-metal such as glass or plastic. The biocide is preferably in the composition in an amount between 0.05 and 1% w/w composition. Most preferably the amount is about 0.2%w/w.
Quick breaking foaming agents are well known. A general discussion may be found in Australian Patent 463216 which is incorporated herein by reference. The preferred agent in the composition of the present invention comprises an aliphatic alcohol, water, a fatty alcohol and a surface active agent. Preferably, the aliphatic alcohol is aqueous ethanol.
The most preferred quick break foaming agent comprises: <ul id="ul0001" list-style="none"><li>(a) An aliphatic alcohol preferably in amounts from 40-90%w/w composition, more preferably 55-70%w/w and most preferably 60%w/w;</li><li>(b) Water preferably in amounts from 10-40%w/w;</li><li>(c) A fatty alcohol, preferably in amounts from 0.5-10%w/w; and</li><li>(d) A surface active agent preferably an ethoxylated sorbitan ester (as emulsifier) typically in amounts from 0.1-15% w/w.</li></ul>
The aerosol propellant should be carefully selected for its compatability with the entire composition. The most preferable propellants may be selected from the group comprising propane, butane, dichloro difluoro methane, dichloro tetra fluoro ethane, and octafluoro cyclo butane. The propellant is preferably present in amounts from 3 to 30% w/w, more preferably from about 5-15%w/w and most preferably 8 to 10% w/w.
Preferred corrosion inhibitors for use in the present invention include organic acid salts such as sorbic acid, benzoic acid, sodium benzoate and potassium sorbate. The preferred amount of corrosion inhibitor is about 0.1 to 15%w/w, more preferably 0.1 to 3%w/w.
The invention will now be more fully described by way of example although it should be understood by those skilled in the art that embodiments of the invention outside the scope of the examples are possible.
BEST MODE OF PERFORMING THE INVENTION
Example 1.
The following formulation is a general formulation which may be used as a basis for more specific formulations thus enabling variation as required for particular circumstances. <tables id="tabl0001" num="0001"><table frame="all"><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="center">%w/w</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">PROPELLANT e.g. propane, butane, dichloro difluoro methane, dichloro tetra fluoro ethane, octafluoro cyclo butane and mixtures thereof</entry><entry namest="col2" nameend="col2" /></row><row><entry namest="col1" nameend="col1" align="right">3-30</entry><entry namest="col2" nameend="col2" /></row><row><entry namest="col1" nameend="col1" /></row><row><entry namest="col1" nameend="col1" align="left">BIOCIDE e.g. parachlorometaxylenol, Benzoyl Peroxide, Triclosan, Sulphur, Salicyclic Acid and mixtures thereof</entry><entry namest="col2" nameend="col2" align="right">0.05-10</entry></row><row><entry namest="col1" nameend="col1" align="left">FATTY ACID e.g. linoleic and/or linolenic acid</entry><entry namest="col2" nameend="col2" align="right">0.5-5</entry></row><row><entry namest="col1" nameend="col1" /></row><row><entry namest="col1" nameend="col1" align="left">FATTY ALCOHOL e.g. cetyl, stearyl, lauryl, myristyl, palmityl, and mixtures thereof</entry><entry namest="col2" nameend="col2" align="right">0.5-10</entry></row><row><entry namest="col1" nameend="col1" /></row><row><entry namest="col1" nameend="col1" align="left">ALIPHATIC ALCOHOL e.g. methyl, ethyl isopropyl, butyl and mixtures thereof</entry><entry namest="col2" nameend="col2" align="right">40-90</entry></row><row><entry namest="col1" nameend="col1" align="left">WATER</entry><entry namest="col2" nameend="col2" align="right">10-40</entry></row><row><entry namest="col1" nameend="col1" /></row><row><entry namest="col1" nameend="col1" align="left">POLYOL e.g. glycerol, propylene glycol, sorbitol and low molecular weight polymers thereof</entry><entry namest="col2" nameend="col2" align="right">1-10</entry></row><row><entry namest="col1" nameend="col1" align="left">ORGANIC ACID SALT e.g. sorbic acid, benzoic acid</entry><entry namest="col2" nameend="col2" align="right">0.1-15</entry></row><row><entry namest="col1" nameend="col1" /></row><row><entry namest="col1" nameend="col1" align="left">SURFACE ACTIVE AGENT e.g. ethoxylated sorbitan stearate, palmitate, oleate, nonyl phenol ethoxylates, fatty alcohol ethoxylates.</entry><entry namest="col2" nameend="col2" /></row><row rowsep="1"><entry namest="col1" nameend="col1" align="right">0.1-15</entry><entry namest="col2" nameend="col2" /></row></tbody></tgroup></table></tables>
The following examples are particularly preferred embodiments of the present invention.
Example 2.
<tables id="tabl0002" num="0002"><table frame="all"><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="center">%w/w</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">cetostearyl alcohol B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">1.60</entry></row><row><entry namest="col1" nameend="col1" align="left">polyoxyethylene sorbitan monostearate N.F.</entry><entry namest="col2" nameend="col2" align="char" char=".">0.40</entry></row><row><entry namest="col1" nameend="col1" align="left">ethanol 95% U.S.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">52.50</entry></row><row><entry namest="col1" nameend="col1" align="left">polyunsaturated fatty acid</entry><entry namest="col2" nameend="col2" align="char" char=".">1.85</entry></row><row><entry namest="col1" nameend="col1" align="left">purified water B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">30.90</entry></row><row><entry namest="col1" nameend="col1" align="left">sodium hydroxide B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">0.25</entry></row><row><entry namest="col1" nameend="col1" align="left">parachlorometaxylenol</entry><entry namest="col2" nameend="col2" align="char" char=".">0.20</entry></row><row><entry namest="col1" nameend="col1" align="left">sodium benzoate B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">1.20</entry></row><row><entry namest="col1" nameend="col1" align="left">propylene glycol B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">2.00</entry></row><row><entry namest="col1" nameend="col1" align="left">fragrance</entry><entry namest="col2" nameend="col2" align="char" char=".">0.10</entry></row><row><entry namest="col1" nameend="col1" align="left">F12/114 (40:60) B.P.</entry><entry namest="col2" nameend="col2" align="char" char="."><u style="single">9.00</u></entry></row><row rowsep="1"><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="char" char=".">100.00</entry></row></tbody></tgroup></table></tables>
Example 3.
<tables id="tabl0003" num="0003"><img file="EP0331489A2_D0001.tif" /></tables>
Example 4.
<tables id="tabl0004" num="0004"><table frame="all"><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="center">%w/w</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">Parachlorometaxylenol</entry><entry namest="col2" nameend="col2" align="char" char=".">0.18</entry></row><row><entry namest="col1" nameend="col1" align="left">linolenic acid</entry><entry namest="col2" nameend="col2" align="char" char=".">0.82</entry></row><row><entry namest="col1" nameend="col1" align="left">myristyl alcohol</entry><entry namest="col2" nameend="col2" align="char" char=".">3.00</entry></row><row><entry namest="col1" nameend="col1" align="left">ethoxylated octylalcohol</entry><entry namest="col2" nameend="col2" align="char" char=".">0.8</entry></row><row><entry namest="col1" nameend="col1" align="left">glycerol</entry><entry namest="col2" nameend="col2" align="char" char=".">2.5</entry></row><row><entry namest="col1" nameend="col1" align="left">isopropyl alcohol</entry><entry namest="col2" nameend="col2" align="char" char=".">60.0</entry></row><row><entry namest="col1" nameend="col1" align="left">potassium sorbate</entry><entry namest="col2" nameend="col2" align="char" char=".">0.3</entry></row><row><entry namest="col1" nameend="col1" align="left">purified water</entry><entry namest="col2" nameend="col2" align="char" char=".">25.4</entry></row><row><entry namest="col1" nameend="col1" align="left">butane propane</entry><entry namest="col2" nameend="col2" align="char" char="."><u style="single">7.0</u></entry></row><row rowsep="1"><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="char" char=".">100.00</entry></row></tbody></tgroup></table></tables>
Example 5.
<tables id="tabl0005" num="0005"><img file="EP0331489A2_D0002.tif" /></tables>
Example 6.
<tables id="tabl0006" num="0006"><table frame="all"><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="center">%w/w</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">cetostearyl alcohol B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">1.60</entry></row><row><entry namest="col1" nameend="col1" align="left">polyoxyethylene sorbitan monostearate N.F.</entry><entry namest="col2" nameend="col2" align="char" char=".">0.40</entry></row><row><entry namest="col1" nameend="col1" align="left">ethanol 95% U.S.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">52.50</entry></row><row><entry namest="col1" nameend="col1" align="left">polyunsaturated fatty acid</entry><entry namest="col2" nameend="col2" align="char" char=".">1.85</entry></row><row><entry namest="col1" nameend="col1" align="left">purified water B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">30.90</entry></row><row><entry namest="col1" nameend="col1" align="left">sodium hydroxide B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">0.25</entry></row><row><entry namest="col1" nameend="col1" align="left">salicylic acid</entry><entry namest="col2" nameend="col2" align="char" char=".">0.20</entry></row><row><entry namest="col1" nameend="col1" align="left">sodium benzoate B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">1.20</entry></row><row><entry namest="col1" nameend="col1" align="left">propylene glycol B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">2.00</entry></row><row><entry namest="col1" nameend="col1" align="left">fragrance</entry><entry namest="col2" nameend="col2" align="char" char=".">0.10</entry></row><row><entry namest="col1" nameend="col1" align="left">F12/114 (40:60) B.P.</entry><entry namest="col2" nameend="col2" align="char" char="."><u style="single">9.00</u></entry></row><row rowsep="1"><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="char" char=".">100.00</entry></row></tbody></tgroup></table></tables>
Example 7.
<tables id="tabl0007" num="0007"><img file="EP0331489A2_D0003.tif" /></tables>
Example 8.
<tables id="tabl0008" num="0008"><table frame="all"><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="center">%w/w</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">Triclosan</entry><entry namest="col2" nameend="col2" align="char" char=".">0.18</entry></row><row><entry namest="col1" nameend="col1" align="left">linolenic acid</entry><entry namest="col2" nameend="col2" align="char" char=".">0.82</entry></row><row><entry namest="col1" nameend="col1" align="left">myristyl alcohol</entry><entry namest="col2" nameend="col2" align="char" char=".">3.00</entry></row><row><entry namest="col1" nameend="col1" align="left">ethoxylated octylalcohol</entry><entry namest="col2" nameend="col2" align="char" char=".">0.8</entry></row><row><entry namest="col1" nameend="col1" align="left">glycerol</entry><entry namest="col2" nameend="col2" align="char" char=".">2.5</entry></row><row><entry namest="col1" nameend="col1" align="left">isopropyl alcohol</entry><entry namest="col2" nameend="col2" align="char" char=".">60.0</entry></row><row><entry namest="col1" nameend="col1" align="left">potassium sorbate</entry><entry namest="col2" nameend="col2" align="char" char=".">0.3</entry></row><row><entry namest="col1" nameend="col1" align="left">purified water</entry><entry namest="col2" nameend="col2" align="char" char=".">25.4</entry></row><row><entry namest="col1" nameend="col1" align="left">butane propane</entry><entry namest="col2" nameend="col2" align="char" char="."><u style="single">7.0</u></entry></row><row rowsep="1"><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="char" char=".">100.00</entry></row></tbody></tgroup></table></tables>
Example 9.
<tables id="tabl0009" num="0009"><img file="EP0331489A2_D0004.tif" /></tables>
Example 10.
<tables id="tabl0010" num="0010"><img file="EP0331489A2_D0005.tif" /></tables>
Example 11.
<tables id="tabl0011" num="0011"><table frame="all"><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="center">%w/w</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">cetostearyl alcohol B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">1.60</entry></row><row><entry namest="col1" nameend="col1" align="left">polyoxyethylene sorbitan monostearate N.F.</entry><entry namest="col2" nameend="col2" align="char" char=".">0.40</entry></row><row><entry namest="col1" nameend="col1" align="left">ethanol 95% U.S.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">53.75</entry></row><row><entry namest="col1" nameend="col1" align="left">polyunsaturated fatty acid</entry><entry namest="col2" nameend="col2" align="char" char=".">1.85</entry></row><row><entry namest="col1" nameend="col1" align="left">purified water B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">34.65</entry></row><row><entry namest="col1" nameend="col1" align="left">sodium hydroxide B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">0.25</entry></row><row><entry namest="col1" nameend="col1" align="left">parachlorometaxylenol</entry><entry namest="col2" nameend="col2" align="char" char=".">0.20</entry></row><row><entry namest="col1" nameend="col1" align="left">sodium benzoate B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">1.20</entry></row><row><entry namest="col1" nameend="col1" align="left">propylene glycol B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">2.00</entry></row><row><entry namest="col1" nameend="col1" align="left">fragrance</entry><entry namest="col2" nameend="col2" align="char" char=".">0.10</entry></row><row><entry namest="col1" nameend="col1" align="left">propane/butane</entry><entry namest="col2" nameend="col2" align="char" char="."><u style="single">4.00</u></entry></row><row rowsep="1"><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="char" char=".">110.00</entry></row></tbody></tgroup></table></tables>
Example 12.
<tables id="tabl0012" num="0012"><table frame="all"><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="center">%w/w</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">cetostearyl alcohol B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">2.1</entry></row><row><entry namest="col1" nameend="col1" align="left">polyoxyethylene sorbitan monostearate N.F.</entry><entry namest="col2" nameend="col2" align="char" char=".">0.40</entry></row><row><entry namest="col1" nameend="col1" align="left">ethanol 95% U.S.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">53.4</entry></row><row><entry namest="col1" nameend="col1" align="left">polyunsaturated fatty acid</entry><entry namest="col2" nameend="col2" align="char" char=".">1.85</entry></row><row><entry namest="col1" nameend="col1" align="left">purified water B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">34.5</entry></row><row><entry namest="col1" nameend="col1" align="left">sodium hydroxide B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">0.25</entry></row><row><entry namest="col1" nameend="col1" align="left">parachlorometaxylenol</entry><entry namest="col2" nameend="col2" align="char" char=".">0.20</entry></row><row><entry namest="col1" nameend="col1" align="left">sodium benzoate B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">1.20</entry></row><row><entry namest="col1" nameend="col1" align="left">propylene glycol B.P.</entry><entry namest="col2" nameend="col2" align="char" char=".">2.00</entry></row><row><entry namest="col1" nameend="col1" align="left">fragrance</entry><entry namest="col2" nameend="col2" align="char" char=".">0.10</entry></row><row><entry namest="col1" nameend="col1" align="left">propane/butane</entry><entry namest="col2" nameend="col2" align="char" char="."><u style="single">4.00</u></entry></row><row rowsep="1"><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="char" char=".">100.00</entry></row></tbody></tgroup></table></tables>
Contents3
5 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO2004080179A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US7186416B2 | Cited by | United States of America | Applicant |
| US6946120B2 | Cited by | United States of America | Applicant |
| EP0582239A1 | Cited by | European Patent Office (EPO) | Search report |
| US7078058B2 | Cited by | United States of America | Applicant |
| US9486394B2 | Cited by | United States of America | Applicant |
| US5631218A | Cited by | United States of America | Search report |
| US5380763A | Cited by | United States of America | Search report |
| WO0180827A2 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US8586008B2 | Cited by | United States of America | Applicant |
| US7655250B2 | Cited by | United States of America | Applicant |
| WO0180827A3 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US5965513A | Cited by | United States of America | Search report |
| JPH06199688A | Cited by | Japan | Search report |
| US8586066B2 | Cited by | United States of America | Applicant |
| US7771753B2 | Cited by | United States of America | Applicant |
| US7749488B2 | Cited by | United States of America | Applicant |
| US7829107B2 | Cited by | United States of America | Applicant |
| US7374747B2 | Cited by | United States of America | Applicant |
| US5965513A | Cited by | United States of America | Search report |
| US8026238B2 | Cited by | United States of America | Applicant |
| DE19611953A1 | Cited by | Germany | Search report |
| EP0582239A1 | Cited by | European Patent Office (EPO) | Search report |
| US7141237B2 | Cited by | United States of America | Applicant |
| WO2004080179A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| WO9403156A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| WO9403156A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US6579516B1 | Cited by | United States of America | Applicant |
| GB2018589A | Cites | United Kingdom | Search report |
| GB2181349A | Cites | United Kingdom | Search report |
| US3535422A | Cites | United States of America | Search report |
| AU463216A1 | Cites | Australia | Applicant |
| AU463216A | Cites | Australia | Search report |
20 members in 13 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 51188 | Australia | – | |
| PJ051188 | Australia | A | |
| 204688 | Australia | – | |
| PJ204688 | Australia | A | |
| 204688 | – | – | – |
| 51188 | – | – | – |
| AU1988PJ00511 | – | – | – |
| AU1988PJ02046 | – | – | – |
Members20
| Document | Office | Kind | |
|---|---|---|---|
| NO890899D0 | Norway | D0 | |
| NO890899L | Norway | L | |
| EP0331489A2This record | European Patent Office (EPO) | A2 | |
| AU3084389A | Australia | A | |
| BR8900962A | Brazil | A | |
| PT89892A | Portugal | A | |
| ZA891541B | South Africa | B | |
| EP0331489A3 | European Patent Office (EPO) | A3 | |
| JPH0296522A | Japan | A | |
| PH25291A | Philippines | A | |
| NZ228188A | New Zealand | A | |
| AU619256B2 | Australia | B2 | |
| EP0331489B1 | European Patent Office (EPO) | B1 | |
| AT91231T | Austria | T | |
| ATE91231T1 | Austria | T1 | |
| DE68907423D1 | Germany | D1 | |
| DE68907423T2 | Germany | T2 | |
| IN172749B | India | B | |
| MY104412A | Malaysia | A | |
| PT89892B | Portugal | B |
30 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents actLapsedNLV1 | NLV1 | EP | |
| Fr: translation not filedEN | EN | EP | |
| Corresponds to:REF | REF | EP | |
| Designated contracting statesAK | AK | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0331489
- Publication, DOCDB
- 0331489
- Publication, EPODOC
- EP0331489
- Application
- 89302081
- Application, DOCDB
- 89302081
- Application, EPODOC
- EP19890302081
Titles3
- German
- Behandlung der Akne
- English
- Acne treatment
- French
- Traitement de l'acné
Classification
- CPC, 11
- A61K31/20
- A61K8/23
- A61K8/347
- A61K8/361
- A61K8/368
- A61K8/38
- A61K31/60
- A61K33/04
- A61Q19/00
- A61P17/00
- A61P43/00
- IPC, 17
- A61K8 00
- A61K8 23
- A61K8 33
- A61K8 34
- A61K8 36
- A61K8 368
- A61K8 38
- A61K31 20
- A61K31 201
- A61K31 202
- A61K31 60
- A61K33 04
- A61K45 00
- A61K47 00
- A61P17 00
- A61P43 00
- A61Q19 00
Designated states13
- Contracting states, 13
- Austria
- Belgium
- Switzerland
- Germany
- Spain
- France
- United Kingdom
- Greece
- Italy
- Liechtenstein
- Luxembourg
- Netherlands (Kingdom of the)
- Sweden